vs
Ecovyst Inc.（ECVT）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
IONIS PHARMACEUTICALS INC的季度营收约是Ecovyst Inc.的1.0倍（$203.3M vs $199.4M），Ecovyst Inc.同比增速更快（34.0% vs -10.3%），Ecovyst Inc.自由现金流更多（$22.9M vs $-159.0M），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 18.7%）
Ecovyst Inc.是一家全球可持续特种材料供应商，主营高性能催化剂与功能性添加剂的研发、生产，产品服务覆盖工业制造、消费品、环保等核心领域，助力全球客户提升运营效率、降低碳排放。
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
ECVT vs IONS — 直观对比
营收规模更大
IONS
是对方的1.0倍
$199.4M
营收增速更快
ECVT
高出44.2%
-10.3%
自由现金流更多
ECVT
多$181.9M
$-159.0M
两年增速更快
IONS
近两年复合增速
18.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.4M | $203.3M |
| 净利润 | — | $-229.4M |
| 毛利率 | 23.4% | 96.1% |
| 营业利润率 | 10.9% | -105.5% |
| 净利率 | — | -112.8% |
| 营收同比 | 34.0% | -10.3% |
| 净利润同比 | — | -119.8% |
| 每股收益（稀释后） | $0.06 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ECVTIONS
| Q4 25 | $199.4M | $203.3M | ||
| Q3 25 | $204.9M | $156.7M | ||
| Q2 25 | $176.1M | $452.0M | ||
| Q1 25 | $143.1M | $131.6M | ||
| Q4 24 | $148.9M | $226.6M | ||
| Q3 24 | $153.9M | $133.8M | ||
| Q2 24 | $154.0M | $225.3M | ||
| Q1 24 | $141.6M | $119.5M |
净利润ECVTIONS
| Q4 25 | — | $-229.4M | ||
| Q3 25 | $-79.3M | $-128.6M | ||
| Q2 25 | $6.0M | $123.6M | ||
| Q1 25 | $-3.6M | $-146.9M | ||
| Q4 24 | — | $-104.3M | ||
| Q3 24 | $14.3M | $-140.5M | ||
| Q2 24 | $8.3M | $-66.3M | ||
| Q1 24 | $1.2M | $-142.8M |
毛利率ECVTIONS
| Q4 25 | 23.4% | 96.1% | ||
| Q3 25 | 25.4% | 98.5% | ||
| Q2 25 | 22.8% | 99.1% | ||
| Q1 25 | 13.3% | 98.9% | ||
| Q4 24 | 28.9% | 98.3% | ||
| Q3 24 | 29.3% | 99.2% | ||
| Q2 24 | 27.3% | 98.2% | ||
| Q1 24 | 23.5% | 98.2% |
营业利润率ECVTIONS
| Q4 25 | 10.9% | -105.5% | ||
| Q3 25 | 13.8% | -102.2% | ||
| Q2 25 | 9.0% | 30.9% | ||
| Q1 25 | -0.7% | -111.6% | ||
| Q4 24 | 15.1% | -48.9% | ||
| Q3 24 | 17.9% | -111.1% | ||
| Q2 24 | 14.1% | -29.3% | ||
| Q1 24 | 9.5% | -125.1% |
净利率ECVTIONS
| Q4 25 | — | -112.8% | ||
| Q3 25 | -38.7% | -82.1% | ||
| Q2 25 | 3.4% | 27.3% | ||
| Q1 25 | -2.5% | -111.6% | ||
| Q4 24 | — | -46.1% | ||
| Q3 24 | 9.3% | -105.0% | ||
| Q2 24 | 5.4% | -29.4% | ||
| Q1 24 | 0.9% | -119.5% |
每股收益（稀释后）ECVTIONS
| Q4 25 | $0.06 | $-1.35 | ||
| Q3 25 | $-0.69 | $-0.80 | ||
| Q2 25 | $0.05 | $0.70 | ||
| Q1 25 | $-0.03 | $-0.93 | ||
| Q4 24 | $-0.26 | $-0.66 | ||
| Q3 24 | $0.12 | $-0.95 | ||
| Q2 24 | $0.07 | $-0.45 | ||
| Q1 24 | $0.01 | $-0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.2M | $2.7B |
| 总债务越低越好 | $392.6M | $1.8B |
| 股东权益账面价值 | $603.4M | $489.1M |
| 总资产 | $1.3B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.65× | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资ECVTIONS
| Q4 25 | $197.2M | $2.7B | ||
| Q3 25 | $82.0M | $2.2B | ||
| Q2 25 | $69.6M | $2.3B | ||
| Q1 25 | $127.5M | $2.1B | ||
| Q4 24 | $131.4M | $2.3B | ||
| Q3 24 | $123.5M | $2.5B | ||
| Q2 24 | $83.3M | $2.1B | ||
| Q1 24 | $103.1M | $2.2B |
总债务ECVTIONS
| Q4 25 | $392.6M | $1.8B | ||
| Q3 25 | $854.8M | — | ||
| Q2 25 | $856.6M | — | ||
| Q1 25 | $859.0M | — | ||
| Q4 24 | $860.8M | $1.3B | ||
| Q3 24 | $862.7M | — | ||
| Q2 24 | $862.4M | — | ||
| Q1 24 | $866.2M | — |
股东权益ECVTIONS
| Q4 25 | $603.4M | $489.1M | ||
| Q3 25 | $607.9M | $618.0M | ||
| Q2 25 | $692.4M | $631.7M | ||
| Q1 25 | $698.7M | $475.7M | ||
| Q4 24 | $700.5M | $588.4M | ||
| Q3 24 | $729.4M | $662.5M | ||
| Q2 24 | $717.3M | $263.7M | ||
| Q1 24 | $711.4M | $296.5M |
总资产ECVTIONS
| Q4 25 | $1.3B | $3.5B | ||
| Q3 25 | $1.7B | $3.0B | ||
| Q2 25 | $1.8B | $3.0B | ||
| Q1 25 | $1.8B | $2.8B | ||
| Q4 24 | $1.8B | $3.0B | ||
| Q3 24 | $1.8B | $3.1B | ||
| Q2 24 | $1.8B | $2.7B | ||
| Q1 24 | $1.8B | $2.8B |
负债/权益比ECVTIONS
| Q4 25 | 0.65× | 3.71× | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | 1.23× | — | ||
| Q4 24 | 1.23× | 2.13× | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.8M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | $22.9M | $-159.0M |
| 自由现金流率自由现金流/营收 | 11.5% | -78.2% |
| 资本支出强度资本支出/营收 | 9.4% | 10.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $69.9M | $-320.0M |
8季度趋势，按日历期对齐
经营现金流ECVTIONS
| Q4 25 | $41.8M | $-137.7M | ||
| Q3 25 | $55.3M | $-131.4M | ||
| Q2 25 | $33.0M | $151.3M | ||
| Q1 25 | $10.3M | $-150.8M | ||
| Q4 24 | $43.5M | $-116.1M | ||
| Q3 24 | $59.9M | $-115.0M | ||
| Q2 24 | $10.0M | $-119.9M | ||
| Q1 24 | $36.5M | $-149.9M |
自由现金流ECVTIONS
| Q4 25 | $22.9M | $-159.0M | ||
| Q3 25 | $53.2M | $-136.7M | ||
| Q2 25 | $7.8M | $139.0M | ||
| Q1 25 | $-14.0M | $-163.4M | ||
| Q4 24 | $30.9M | $-141.6M | ||
| Q3 24 | $53.6M | $-124.0M | ||
| Q2 24 | $-9.3M | $-126.1M | ||
| Q1 24 | $19.1M | $-154.4M |
自由现金流率ECVTIONS
| Q4 25 | 11.5% | -78.2% | ||
| Q3 25 | 26.0% | -87.2% | ||
| Q2 25 | 4.4% | 30.8% | ||
| Q1 25 | -9.8% | -124.1% | ||
| Q4 24 | 20.7% | -62.5% | ||
| Q3 24 | 34.9% | -92.7% | ||
| Q2 24 | -6.1% | -56.0% | ||
| Q1 24 | 13.5% | -129.2% |
资本支出强度ECVTIONS
| Q4 25 | 9.4% | 10.5% | ||
| Q3 25 | 1.0% | 3.4% | ||
| Q2 25 | 14.4% | 2.7% | ||
| Q1 25 | 16.9% | 9.6% | ||
| Q4 24 | 8.5% | 11.3% | ||
| Q3 24 | 4.1% | 6.8% | ||
| Q2 24 | 12.5% | 2.8% | ||
| Q1 24 | 12.3% | 3.8% |
现金转化率ECVTIONS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.52× | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.21× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 29.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
